Cutaneous sarcoidosis and infliximab: evidence for efficacy in refractory disease.

@article{Tu2014CutaneousSA,
  title={Cutaneous sarcoidosis and infliximab: evidence for efficacy in refractory disease.},
  author={Jenny Tu and Jonathan J Chan},
  journal={The Australasian journal of dermatology},
  year={2014},
  volume={55 4},
  pages={279-81}
}
Biological therapy with tumour necrosis factor alpha antibodies continues to offer a life-changing option for a range of autoimmune and inflammatory skin conditions. We present three cases of sarcoidosis, with refractory cutaneous disease successfully treated with infliximab. A review of the literature shows increased numbers of cases of refractory cutaneous sarcoidosis successfully cleared with infliximab therapy. 
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-8 of 8 references

Similar Papers

Loading similar papers…